Consistent with existing literature, our analysis identified erythrocytosis-related parameters, including HCT ≥0.42, RBC ≥4.7×1012/L, and Hb ≥136 g/L, as risk factors for thrombotic events in MPN patients. The gene discussed is GSTM1; the disease is myeloproliferative neoplasm.